BusinessIndustry

Insights Reports On Drug Screening Market : Industrial Analysis With Quest Diagnostics, Siemens Healthineers, Roche, Abbott, Thermo Fisher Scientific

The market report also contains the drivers and restraints for the Drug Screening market that are obtained with the help of SWOT analysis, and also shows all the recent developments, product launches, joint ventures, mergers and acquisitions by the several key players and brands with their systemic company profiles, that are driving the market. It is the most appropriate, rational and admirable Drug Screening market research report provided with a devotion and comprehension of business needs. Quality and transparency has been strictly maintained while carrying out research studies to provide an exceptional market research report for a niche.

Drug screening market is expected to rise gradually to an estimated value of USD 19.03 billion by 2026, registering a CAGR of 12.9% in the forecast period of 2019-2026 with the annual sales of USD 7.21 billion in the year 2018. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of people.

Get Sample Analysis of Global Market Information: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-screening-market   

Drug screening is used for detecting prescribed as well as illegal drugs in blood, urine, and other biological samples basically at hospitals, places of employment, trained athletes, schools and post-accident. It is considered as a basic part of ongoing diagnosis and treatment, can be by purpose or random. Drug screening takes place at the time of some suspicious cause, generally before employment or sports event. Few of the illegal drugs are cocaine, heroin, amphetamine and cannabis along with which new psychoactive substances (NPS), for instance, ketamine, phenethylamines, and piperazine are rising in the drug market.

According to World Health Organization, there were an estimated 3.3 million people died due to harmful effects of only alcohol, almost more than half of these deaths could have been avoided with the development, organization, monitoring and evaluation of treatment and other services. This significant number is expected to act as a driver to the market growth.

Key Developments in the Market:

  • On 6thJuly, 2017, Endo Pharmaceuticals agreed to remove Opana ER (oxymorphone), its abuse-deterrent extended-release formulation of from the US market a month later the US Food and Drug Administration (FDA) asked the company to stop selling the pain medication.
  • On 19thJuly 2017, Alere Inc., a global leader in rapid diagnostics, announced the availability of Alere iCup , its point-of-care Rx Drug Screen, a rapid urine test that detects five of the most commonly misused and abused prescription drugs which are benzodiazepines, buprenorphine, methadone, opiates and oxycodone. This innovative approach will help the company to generate more revenue.

Few of the major competitors currently working in the drug screening market are Siemens Healthcare GmbH (Germany), Quest Diagnostics Incorporated (U.S.), Alere (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Abbott (U.S.),Hoffmann -La Roche Ltd(Switzerland), BioMerieux SA (France),  Express Diagnostics Int’l, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories Inc. (U.S), Biomedical Diagnostics (Belgium),  CannAmm (Cannada), MPD, Inc. (U.S.), Danaher (U.S.), Synergy Health plc.(U.K), Agilent Technologies (U.S), Shimadzu Medical Pvt. Ltd. (Japan) and few among others.

 Market Drivers

  • Increasing government funding and initiatives for drug testing.
  • Rising awareness on drug screening policy
  • Growing alcohol and drug abuse in developing countries.

 Get TOC of Full Report: https://databridgemarketresearch.com/toc/?dbmr=global-drug-screening-market

Market Restraints

  • In some countries drug testing is considered as a violation of privacy rights.
  • Accuracy issues with the breathalyzers.

Segmentation: Global Drug Screening Market

By Product and services

  • Equipment
  • Immunoassay Analyzers
  • Chromatography Instruments
  • Breath Analyzers
    • Fuel Cell Breathalyzers
    • Semiconductor Breathalyzers
    • Other Devices
  • Rapid Testing Devices
  1. Urine Testing Devices
  • Urine Testing Cups
  • Dip Cards
  • Cassettes
  1. Oral Fluid Testing Devices
  • Consumables
  • Assay Kits
  • Sample Collection Cups
  • Calibrators and Controls
  • Others
  • Laboratory Services

By Sample Type

  • Urine
  • Breath
  • Saliva, Hair
  • Blood
  • Skin
  • Sweat

By End- users

  • Workplace and Schools
  • Drug Testing Laboratories
  • Criminal Justice System & Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Pain Management Centers
  • Personal Users

By Geography

  • North America
    • US.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

 Global drug screening market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of drug screening market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

 Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-drug-screening-market

 

About Us

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing [email protected] . We are content with our glorious 99.9 % client satisfying rate.


Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475
Mail: [email protected]
https://databridgemarketresearch.com

 

Report Rating
Close